Skip to main content

Table 4 Vaccine coverage of preterm cohorts 2016–17 and historical 2012–14 preterm cohort (z-test)

From: In-hospital and web-based intervention to counteract vaccine hesitancy in very preterm infants’ families: a NICU experience

Vaccine

Preterm cohort

Preterm historical cohort

p

n/N

% (95%CI)

n/N

% (95%CI)

DTaP-IPV-HBV-Hib 1 doses

169/170

99.4 (96.3–100.0)

156/159

98.1 (94.6–99.6)

0.568

DTaP-IPV-HBV-Hib 2 doses

165/168

98.2 (94.5–99.5)

145/159

91.2 (85.7–95.1)

0.009

DTaP-IPV-HBV-Hib 3 doses

161/167

96.4 (92.0–98.5)

138/158

87.3 (81.1–92.1)

0.005

PCV 1 doses

167/170

98.2 (94.7–99.5)

157/159

98.7 (95.5–99.8)

> 0.99

PCV 2 doses

160/168

95.2 (90.5–97.8)

144/159

90.6 (84.9–94.6)

0.151

PCV 3 doses

152/167

91.0 (85.4–94.7)

136/158

86.1 (79.7–91.1)

0.220

Men C

137/167

82.0 (75.2–87.4)

135/157

86.0 (79.6–91.0)

0.414

MMR

158/167

94.6 (89.7–97.3)

120/157

76.4 (69.0–82.8)

< 0.001

Varicella

158/167

94.6 (89.7–97.3)

127/157

80.9 (73.9–86.7)

< 0.001